Urology · Knoxville, TN
NPI
1770754137
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
9245 Park West Blvd
Knoxville, TN, 37923
Phone (865) 690-3811
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
13,115 services
Medicare patients, 2024
1,106
Average age 76
Drug cost, 2024
$13.7M
4,365 prescriptions
Company payments, 2025
$2,536
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy J Leroy was code J9155 (injection, degarelix, 1 mg), 2,320 times for 11 patients. In total Timothy J Leroy billed 13,115 services in 100 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9155 Injection, degarelix, 1 mg | Office | 2,320 | 11 | $3.28 | $7,602 |
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 20 | $20.40 | $40K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,334 | 164 | $45.32 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,150 | 799 | $11.21 | $13K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 956 | 127 | $42.78 | $41K |
| 81003 Clinical Chemistry | Office | 850 | 671 | $2.17 | $1,845 |
| 99214 Office E&M - Established | Office | 564 | 384 | $83.56 | $47K |
| 99213 Office E&M - Established | Office | 480 | 407 | $58.09 | $28K |
| 36415 Venipuncture Blood Collection | Office | 474 | 340 | $8.60 | $4,077 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 325 | 119 | $34.94 | $11K |
| 52000 Cystourethroscopy | Facility | 188 | 149 | $53.20 | $10K |
| 51798 Ultrasound - Nonspecific | Office | 181 | 160 | $6.92 | $1,253 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 169 | 28 | $136.57 | $23K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 132 | 114 | $38.82 | $5,124 |
| 74018 Standard X-ray | Office | 127 | 109 | $17.50 | $2,223 |
By year: 2022 $563K for 8,323 services; 2023 $606K for 11,611 services; 2024 $1.1M for 13,115 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 850 | 671 | $2.17 | $1,845 |
| 36415 Venipuncture Blood Collection | 474 | 340 | $8.60 | $4,077 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy J Leroy prescribed most often to Medicare patients was Tamsulosin Hcl, with 911 prescriptions and refills. In total Timothy J Leroy wrote 4,365 Medicare prescriptions that cost $13.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 911 | 2,534 | 303 | $11K |
| Finasteride Generic | 542 | 1,566 | 165 | $7,182 |
| Orgovyx Relugolix | 455 | 461 | 60 | $1.3M |
| Xtandi Enzalutamide | 427 | 439 | 58 | $6.0M |
| Erleada Apalutamide | 223 | 225 | 33 | $3.2M |
| Nubeqa Darolutamide | 216 | 216 | 26 | $2.8M |
| Prednisone Generic | 158 | 165 | 26 | $956 |
| Abiraterone Acetate Generic | 153 | 153 | 24 | $239K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 143 | 143 | 127 | $529 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 127 | 311 | 37 | $2,805 |
| Gemtesa Vibegron | 109 | 179 | 29 | $85K |
| Myrbetriq Mirabegron | 103 | 189 | 36 | $84K |
| Cephalexin Generic | 90 | 92 | 81 | $380 |
| Ciprofloxacin Hcl Generic | 88 | 88 | 83 | $203 |
| Oxybutynin Chloride Generic | 58 | 130 | 16 | $1,186 |
Brand drugs: - claims; generic drugs: 2,765 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy J Leroy $2,536 ($2,536 in general payments such as food, travel and fees) from 28 companies. The largest payer was Dendreon Pharmaceuticals LLC with $332.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 12 | $332 |
| Boston Scientific Corporation BSX | 14 | $240 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $192 |
| Urogen Pharma, Inc. URGN | 6 | $182 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $174 |
| Abbvie Inc. ABBV | 10 | $168 |
| Telix Pharmaceuticals TLX | 6 | $155 |
| Pfizer Inc. PFE | 7 | $142 |
| Janssen Biotech, Inc. JNJ | 8 | $125 |
| Astellas Pharma US Inc 4503.T | 5 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.